How to efficiently characterize the interaction pathways of protein–ligand recognition? A comparative analysis on enhanced sampling approaches

Z Zhiliang Jiang (Department of Medicinal Chemistry, China Pharmaceutical University 1 , Nanjing 210009, Jiangsu,) M Mingyun Shen (School of Elite Biomedical Engineers, China Pharmaceutical University 2 , Nanjing 210009, Jiangsu,) Z Zhe Wang S Sutong Xiang (Department of Medicinal Chemistry, China Pharmaceutical University 1 , Nanjing 210009, Jiangsu,) Q Qirui Deng (Department of Medicinal Chemistry, China Pharmaceutical University 1 , Nanjing 210009, Jiangsu,) K Kexin Xu K Kaimo Yang (Department of Medicinal Chemistry, China Pharmaceutical University 1 , Nanjing 210009, Jiangsu,) C Chen Yin Z Zihao Wang T Tingjun Hou (College of Pharmaceutical Sciences) H Huiyong Sun (Department of Medicinal Chemistry, China Pharmaceutical University 1 , Nanjing 210009, Jiangsu,)

Abstract

It is evidenced that many elaborately designed molecules that can interact well with the binding pocket of their target fail to exhibit activity in wet-lab experiments. This may associate with the interacting process of drug-target recognition. To efficiently characterize the drug-target interacting process, various enhanced sampling technologies have been proposed; yet, very few studies have systemically investigated whether the settings of these simulations are favorable to characterize the purposed tasks. Here, by comparing two popular enhanced sampling technologies, namely, the well-temped metadynamics and random acceleration molecular dynamics (RAMD), we systemically investigate the strategies to efficiently characterize the dissociating process of protein–ligand interactions. Two target families are employed for the analysis, including the kinase family (represented by TRK1) that represents the interaction-pathway obvious systems and the nuclear receptor family (represented by THRβ) that represents the interaction-pathway unobvious systems. Our results suggest that (1) in terms of maintaining stability of the protein structure, MetaD at various simulation conditions and RAMD with a large random force are good choice; (2) drug residence time derived from both MetaD and RAMD based on various parameters shows reasonable correlation to the experimental binding strength of the ligands, but RAMD usually runs with much less simulation time; and (3) both enhanced sampling methods result in reasonably consistent pathway preference for the two target families. Taken together, it will be much time-saving to utilize RAMD with high random force for interaction pathway exploration for both the pathway obvious and unobvious systems if the protein keeps stable in the simulation; otherwise, MetaD with a high bias factor is proposed to balance the computational accuracy and efficiency for the exploration.

Article Details

Volume / Issue Vol. 164, Issue 2
Published January 14, 2026
ISSN 0021-9606
Publisher American Institute of Physics

Journal Info

The Journal of Chemical Physics

American Institute of Physics

ISSN: 0021-9606 Physical Sciences

Authors (11)

Z

Zhiliang Jiang

Department of Medicinal Chemistry, China Pharmaceutical University 1 , Nanjing 210009, Jiangsu,

M

Mingyun Shen

School of Elite Biomedical Engineers, China Pharmaceutical University 2 , Nanjing 210009, Jiangsu,

Z

Zhe Wang

S

Sutong Xiang

Department of Medicinal Chemistry, China Pharmaceutical University 1 , Nanjing 210009, Jiangsu,

Q

Qirui Deng

Department of Medicinal Chemistry, China Pharmaceutical University 1 , Nanjing 210009, Jiangsu,

K

Kexin Xu

K

Kaimo Yang

Department of Medicinal Chemistry, China Pharmaceutical University 1 , Nanjing 210009, Jiangsu,

C

Chen Yin

Z

Zihao Wang

T

Tingjun Hou

College of Pharmaceutical Sciences

H

Huiyong Sun

Department of Medicinal Chemistry, China Pharmaceutical University 1 , Nanjing 210009, Jiangsu,